Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Dexamethasone rescues fertility in unexplained recurrent endometrial cavity fluid patients via the NR3C1/PER1/SCNN1A-autophagy axis.

Created on 15 Nov 2026

Authors

Zhonghong Zeng, Dan Mo, Tianxia Xiao, Wenhong Ma, Hao Sun, Mengqing Gu, Haiyan Huang, Yueqi Leng, Mingmei Lin, Shizhan Cui, Yandong Chen, Ping Zhou, Xunsi Qin, Xuejiao Piao, Dezhi Mao, Jiayi Ma, Yongjin Luo, Yusong Liu, Chen Liang, Pengfei Luan, Zhen Wang, Xiaojuan Liu, Yihua Yang, Yang Yu, Rong Li

Published in

Journal of advanced research. Nov 14, 2026. Epub Nov 14, 2026.

Abstract

Unexplained recurrent endometrial cavity fluid (ECF) is a poorly understood condition that severely impairs embryo implantation and IVF outcomes, yet no targeted therapy exists.
To bridge this gap, our study shifts the clinical paradigm from symptomatic observation to mechanism-based intervention.
We used a novel patient-derived organoid model that recapitulates the key phenotypic features of unexplained recurrent ECF in vitro.
We found that unexplained recurrent ECF primarily results from reduced fluid absorption (due to a reduction in SCNN1A), rather than increased fluid secretion. Beyond its role in fluid homeostasis, SCNN1A deficiency was shown to overactivate autophagy in patient-derived endometrial organoids, leading to a loss of ciliated cells and disruption of adherens junction integrity. This cascade creates a vicious cycle that further aggravates unexplained recurrent ECF. Notably, model-based drug screening showed phenotypic rescue of patient-derived organoids by dexamethasone (DXMS) via the NR3C1/PER1/SCNN1A-autophagy pathway.
These results revealed the pathological mechanism underlying unexplained recurrent ECF patients and provided a proposed pathway and tangible evidence to support personalized treatment strategies for this challenging condition.

PMID:
43033908
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement